Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Diagnosis of viral hepatitis.

Easterbrook PJ, Roberts T, Sands A, Peeling R.

Curr Opin HIV AIDS. 2017 May;12(3):302-314. doi: 10.1097/COH.0000000000000370. Review.

2.

Who to test and how to test for chronic hepatitis C infection - 2016 WHO testing guidance for low- and middle-income countries.

Easterbrook PJ; WHO Guidelines Development Group.

J Hepatol. 2016 Oct;65(1 Suppl):S46-S66. doi: 10.1016/j.jhep.2016.08.002. Review.

PMID:
27641988
3.

HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions.

Easterbrook P, Johnson C, Figueroa C, Baggaley R.

AIDS Rev. 2016 Jan-Mar;18(1):3-14. Review.

PMID:
26991825
4.

The future of viral hepatitis testing: innovations in testing technologies and approaches.

Peeling RW, Boeras DI, Marinucci F, Easterbrook P.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):699. doi: 10.1186/s12879-017-2775-0. Review.

5.

Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.

Ishizaki A, Bouscaillou J, Luhmann N, Liu S, Chua R, Walsh N, Hess S, Ivanova E, Roberts T, Easterbrook P.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):696. doi: 10.1186/s12879-017-2767-0.

6.

Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.

Kania D, Bekalé AM, Nagot N, Mondain AM, Ottomani L, Meda N, Traoré M, Ouédraogo JB, Ducos J, Van de Perre P, Tuaillon E.

Clin Microbiol Infect. 2013 Dec;19(12):E533-41. doi: 10.1111/1469-0691.12292. Epub 2013 Jul 31.

7.

One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.

Parry JV, Easterbrook P, Sands AR.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):705. doi: 10.1186/s12879-017-2774-1.

8.

Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis.

Grebely J, Applegate TL, Cunningham P, Feld JJ.

Expert Rev Mol Diagn. 2017 Dec;17(12):1109-1115. doi: 10.1080/14737159.2017.1400385. Epub 2017 Nov 8. Review.

PMID:
29088981
9.

Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.

Easterbrook P, Sands A, Harmanci H.

Semin Liver Dis. 2012 May;32(2):147-57. doi: 10.1055/s-0032-1316476. Epub 2012 Jul 3. Review.

PMID:
22760654
10.

Economic evaluation of HCV testing approaches in low and middle income countries.

Morgan JR, Servidone M, Easterbrook P, Linas BP.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):697. doi: 10.1186/s12879-017-2779-9. Review.

11.

Point-of-care testing for HCV infection: recent advances and implications for alternative screening.

Parisi MR, Soldini L, Vidoni G, Mabellini C, Belloni T, Brignolo L, Negri S, Schlusnus K, Dorigatti F, Lazzarin A.

New Microbiol. 2014 Oct;37(4):449-57. Epub 2014 Oct 1.

12.

Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile.

Ivanova Reipold E, Easterbrook P, Trianni A, Panneer N, Krakower D, Ongarello S, Roberts T, Miller V, Denkinger C.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):707. doi: 10.1186/s12879-017-2770-5.

13.

Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: results of a survey of end users and implementers.

Reipold EI, Trianni A, Krakower D, Ongarello S, Roberts T, Easterbrook P, Denkinger C.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):702. doi: 10.1186/s12879-017-2769-y.

15.

Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.

Abruzzi A, Fried B, Alikhan SB.

Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5. Review.

PMID:
27015949
16.

Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples - a systematic review and meta-analysis.

Lange B, Roberts T, Cohn J, Greenman J, Camp J, Ishizaki A, Messac L, Tuaillon E, van de Perre P, Pichler C, Denkinger CM, Easterbrook P.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):693. doi: 10.1186/s12879-017-2776-z. Review.

17.

Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.

McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.

J Clin Virol. 2006 Jul;36(3):166-76. Epub 2006 Jan 20.

PMID:
16427802
18.

[Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].

Contreras AM, Ochoa-Jiménez RJ, Kershenobich D, Granados-García V, Conde-González CJ, Celis A, Pérez-Gómez HR, Ruelas-Hernández S, Romero-Flores P, Alcántar-Luna E, Sierra-García de Quevedo J, Ancona-Pisté O; Grupo de Desarrollo de la Guía.

Rev Invest Clin. 2012 Nov-Dec;64(6 Pt 2):641-78. Spanish.

PMID:
23593783
19.

Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses.

Lange B, Cohn J, Roberts T, Camp J, Chauffour J, Gummadi N, Ishizaki A, Nagarathnam A, Tuaillon E, van de Perre P, Pichler C, Easterbrook P, Denkinger CM.

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):700. doi: 10.1186/s12879-017-2777-y. Review.

20.

Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection: A Systematic Review and Meta-analysis.

Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, Easterbrook PJ, Linas BP, Denkinger CM.

Ann Intern Med. 2016 Sep 6;165(5):345-55. doi: 10.7326/M16-0065. Epub 2016 Jun 21. Review.

Supplemental Content

Support Center